Ostergaard M, van Vollenhoven RF, Rudin A, Hetland ML, et al. Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial. Ann Rheum Dis 2023 Jul 9:ard-2023-224116. doi: 10.1136/ard-2023-224116.
PMID: 37423647